Dasatinib Accord Healthcare

Medicinal product

(Invented) name

Dasatinib Accord Healthcare

Active substance (s)

Dazatinibas

Strength

50 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

L01EA02, dasatinib

Marketing authorisation holder

Accord Healthcare S.L.U., Ispanija

Date of authorisation

2024-07-26

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

10(1)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Tabletėje yra:	1 vnt.
Dazatinibas	50 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
114675	100782	1100782	lizdinė plokštelė	N56		Receptinis	EU/1/24/1839/005	Netiekiama	-	-	No	-	-
114676	100783	1100783	lizdinė plokštelė	N60		Receptinis	EU/1/24/1839/006	Netiekiama	-	-	No	-	-
114677	100784	1100784	dalomoji lizdinė plokštelė	N56×1		Receptinis	EU/1/24/1839/007	Netiekiama	-	-	No	-	-
114678	100785	1100785	dalomoji lizdinė plokštelė	N60×1		Receptinis	EU/1/24/1839/008	Netiekiama	-	-	No	-	-
118371	104477	1104477	dalomoji lizdinė plokštelė	N10×1		Receptinis	EU/1/24/1839/026	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2024-07-26	Registruotas